Module 2
Summary
This module will provide you with a solid basis for evaluating the opportunities and consequences related to different types of products and submissions. It will also teach you how to plan and operate within the framework of the various application procedures.
While Module 1, "The Pharmaceutical Law Frameworks in the EU", provides you with knowledge of the pharmaceutical legislation in the EU, Module 2 focuses on the implementation of this legislation, e.g., on the procedural and operational aspects when applying for marketing authorizations, clinical trials and orphan drug designations in the EU. You will also learn how to comply with the EU requirements for pediatric investigation plans and risk management plans as well as how to obtain scientific advice from EU authorities.
OTHER COURSE PARTICIPANTS SAY:
“Course content, speakers and organisation met my expectations, in some cases even exceeded them. I highly recommend this course".
Dr. Kristina Mueller, Preclinical Expert.
Keywords
- Regulatory Affairs in the EU
- Marketing Authorization Applications
- Scientific Advice
- Post-Approval Activities
- Pediatric Procedures
- Clinical Trials Applications
- Risk Management
- Orphan Medicinal Products
Hi!
Do you need help choosing the right course?
We are ready to help you at +45 39 27 60 60 or contact@atriumcph.com
PLEASE NOTE:
As this module is a mandatory module in the Master of Medicines Regulatory Affairs at the University of Copenhagen you will apply via the joint Atrium and University of Copenhagen application form. This means that you will be enrolled at both Atrium and the University of Copenhagen and that your data will be registered at both institutions. If you are not enrolled as a master student, you will be registered as a single course student at the University of Copenhagen.
Course fee includes examination. By default you will pay the full amount to the University of Copenhagen regardless of you taking the exam or not. If you decide not to take the exam, you can apply for a refund of the exam fee at Atrium by contacting Atrium - please see contact details below. You must apply for a refund no later than two weeks after completion of the course.
Save information for later
Course leader(s) & Lecturer(s)
- Eva Maiken HolckCourse leaderRegulatory Affairs senior RA CMC specialist
Nykode Therapeutics - Mette Due Theilade ThomsenCourse leaderManaging Director
PIP Adviser - Hans HooglandLecturerSenior Regulatory Specialist
LEO PHARMA A/S - Beatriz da Silva LimaLecturerProfessor of Pharmacology
Universitet Lissabon (University of Lisbon) - Peter BachmannLecturerHead International Liaison Office and Conferences, Executive Department European Union and International Affairs
German Federal Institute for Drugs and Medical Devices (BfArM) - David KingLecturerSenior Director of Regulatory Affairs at HealxStirling, Scotland, United Kingdom
Healx - Janina KarresLecturerPaediatric Coordinator, Human Medicines, Special Areas
EMA - European Medicines Agency - Ingrid PrieschlLecturerRegulatory Consultant
Zwiers Regulatory Consultancy BV - David DavidRJonesLecturerBSc, MSc, EurBiol, CBiol, MIBiol, Registered Toxicologist, Independent consulting
UNKNOWN - Samuel David RamsdenLecturerHead of Risk Management Office
Boehringer Ingelheim Pharma GmbH & Co. KG - Ana CoelhoLecturerRegulatory Affairs Officer
EMA - European Medicines Agency
IS THIS COURSE FOR YOU?
Whether you are new to the field or have several years of experience, this course is relevant if you are a Regulatory Affairs Professional who wants to improve your knowledge and skills.
What you will learn
- To understand the EU regulatory framework and the various types of applications and procedures
- How to evaluate the opportunities and consequences related to different types of products and submissions
- How to analyze the overall strategic choices for the regulatory procedures used during development, application, and maintenance of the medicinal product
- How to use best practices when handling various applications and procedures as well as when interacting with the European Authorities
What your company will get
- A regulatory professional who understands and can operate within the framework of the various application procedures in the EU
- A regulatory professional who can evaluate and analyze the strategic choices related to different types of submissions
- A regulatory professional who can provide valuable input to the regulatory procedures used during the development, application, and maintenance of the medicinal product
- An employee who can play an important strategic role in any project team working on obtaining a marketing authorization in the EU
Course calendar
DAY 1
- Marketing Authorisation Applications – Overview, Terminology and Organisation
- The Centralised Procedure – EMA Perspective
- The Centralised Procedure - Examples of a discussion in CHMP
- Group work
- Scientific advice from CHMP and national competent authorities
- Group work
- Networking with tapas
DAY 2
- Summary of day 1 and introduction to day 2
- New applications in the decentralized/mutual recognition procedure (incl. break)
- Orphan medicinal products
- Group work
- Clinical trial applications in a Pan-European view
- Referrals
- Group work
DAY 3
- Summary of day 2 and introduction to day 3
- Paediatrics – procedural perspective
- Post-approval activities
- Health technology assessment – HTA
- Risk Management
- Group work
- Wrap-up and goodbye
Registration
Registration deadline9 Aug 2023
Lersø Parkallé 101
2100 København Ø
Course information
Literature
Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.
Please familiarize yourself with the mandatory readings before starting the course.
The mandatory readings are also part of the examination syllabus.
Prerequisites
To enroll in this course, you must have a relevant educational background at bachelor level and, as a minimum, two years of experience in regulatory affairs, or other equivalent qualifications. We consider all applications upon registration.
If you do not fulfill the requirements, you can still apply for the course if you have experience in the pharmaceutical/biological area that would allow you to benefit from the training and enable you to participate actively during the module. Up to 20% of the positions on our course are filled by applicants who have no or limited experience in regulatory affairs. We consider applicants on a case-by-case basis.
Examination
The exam is usually held 4-6 weeks after the course.
It is a digital exam in the University of Copenhagen’s digital exam system.
This course is a part of this programme
This diploma in regulatory affairs gives you an understanding of the entire ‘regulatory affairs platform’ of the medicinal product lifecycle. All courses have been designed in collaboration with highly acclaimed experts, that are on our regulatory affairs faculty board
Read moreMaster of Medicines Regulatory Affairs (MRA)
Are you a regulatory affairs professional and are you concerned with your ongoing learning and development consider these courses, offered in development with University of Copenhagen. Explore the Master of Medicines Regulatory Affairs (MRA)
Read moreCourse leader(s)
Nykode Therapeutics
PIP Adviser
Lecturer(s)
LEO PHARMA A/S
Universitet Lissabon (University of Lisbon)
German Federal Institute for Drugs and Medical Devices (BfArM)
Healx
EMA - European Medicines Agency
Zwiers Regulatory Consultancy BV
UNKNOWN
Boehringer Ingelheim Pharma GmbH & Co. KG
EMA - European Medicines Agency
You may also be interested in these courses
WANT TO KNOW MORE or need help?
Contact Client Manager Mette Ribergaard Rasmussen at +45 39 15 09 30
Send me a message